EGFR and neoplasm: While aberrant ErbB signaling has long been known to play a critical role in tumor growth, angiogenesis, invasion, metastatization and resistance to therapy (10), more recent evidence has revealed its impact on other aspects of cancer cells’ biology, such as the ability to evade antitumor immunity (16).